Gullo, G., Kennedy, J., Breathnach, O., McCaffrey, J., Keane, M., Martin, M., Gupta, R., Leonard, G., Calvert, P., Donnellan, P., Walshe, J., Mc Dermott, E., Cairney, S., Bose, R., Scott, K., Hernando, A., Parker, I., Tryfonopoulos, D., Moulton, B., & Crown, J. (n.d.). 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. European journal of cancer, 51, S321–. http://access.bl.uk/ark:/81055/vdc_100030628182.0x00002e